Skip to main content

Table 3 Neurocognitive outcome measures

From: The use of everolimus in the treatment of neurocognitive problems in tuberous sclerosis (TRON): study protocol for a randomised controlled trial

 

Name of measure

Eligibility visit screening measures

Wechsler Abbreviated Scale of Intelligence (four subtests) [17]

Edinburgh Handedness Inventory [18]

Primary outcome measures

Complex Figure test and List Learning test from the BIRT Memory and Information Processing Battery [20]

Spatial Working Memory and Stockings of Cambridge from the CANTAB [21]

Telephone search dual task from the Test of Everyday Attention [22]

Secondary outcome measures

Information Processing Battery, spatial span and attentional set-shifting (IDED) from the CANTAB [21]

Cancellation task and Verbal Fluency from the Controlled Oral Word Association Test [23]

Symptom Checklist-90-Revised [24]

Quality of Life in Epilepsy [25]

Liverpool Seizure Severity Scale [26]

Vineland Adaptive Behaviour Scales-II (survey form) [27]

Social Responsiveness Scale – Adult version [28]

Social Communication Questionnaire [29]

National Adult Reading Test [19]

  1. Abbreviations: BIRT Brain Injury Rehabilitation Trust, CANTAB Cambridge Neurocognitive Test Automated Battery, IDED intra-dimensional/extra-dimensional